(Q34536863)

2 August 2017

title

Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery (English)

1 reference

2 August 2017

Donald R Mehlisch

1

1 reference

2 August 2017

Paul J Desjardins

series ordinal

2

1 reference

2 August 2017

Stephen Daniels

series ordinal

3

1 reference

2 August 2017

Richard C Hubbard

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Journal of Oral and Maxillofacial Surgery

2 August 2017

published in

1 reference

2 August 2017

volume

61

1 reference

2 August 2017

issue

9

1 reference

2 August 2017

page(s)

1030-1037

1 reference

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Efficacy of Nonsteroidal Anti-Inflammatory Drugs in the Management of Postoperative Pain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Peri-operative use of nonsteroidal anti-inflammatory drugs in children: analgesic efficacy and bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Severe postoperative hemorrhage attributed to single-dose parenteral ketorolac-induced coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Effects of ketorolac tromethamine on hemostasis in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Ketorolac doses reduced

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Comparison of the efficacy and safety of ketorolac and meperidine in the relief of dental pain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

A model to evaluate mild analgesics in oral surgery outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2391%2803%2900315-X

7 January 2021

10.1016/S0278-2391(03)00315-X

Identifiers

DOI

1 reference

2 August 2017

1 reference